2019
DOI: 10.1007/s12253-019-00656-7
|View full text |Cite
|
Sign up to set email alerts
|

Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 32 publications
2
10
0
Order By: Relevance
“…Therefore, we aimed to elucidate the roles and mechanisms of the regulation of UHRF1 in trophoblasts that further contribute to RPL. Previous studies have shown that UHRF1 can inhibit or promote the proliferation of many cancer cells and immune cells 23,26,47,48 . However, our results showed that the proliferative capacity of the trophoblasts was not affected by UHRF1 deficiency, which was confirmed by the detection of targeted DNA synthesis.…”
Section: Discussionsupporting
confidence: 60%
“…Therefore, we aimed to elucidate the roles and mechanisms of the regulation of UHRF1 in trophoblasts that further contribute to RPL. Previous studies have shown that UHRF1 can inhibit or promote the proliferation of many cancer cells and immune cells 23,26,47,48 . However, our results showed that the proliferative capacity of the trophoblasts was not affected by UHRF1 deficiency, which was confirmed by the detection of targeted DNA synthesis.…”
Section: Discussionsupporting
confidence: 60%
“…On the contrary, CADM1, as a representative of 18 downregulated DEGs, was found to negatively regulate the phenotype of RB cells. Several previous studies have shown that UHRF1 is related to the occurrence and development of RB ( 19 , 20 ). This study reveals the key role of UHRF1 in RB from the perspective of bioinformatics, further supporting UHRF1 as a potential diagnostic and therapeutic biomarker for RB.…”
Section: Discussionmentioning
confidence: 98%
“…By promoting proliferation and differentiation, UHRF1 regulates the VSMC phenotype, and it may hold therapeutic potential in vascular pathologies [66]. Silencing UHRF1 inhibits cell proliferation and promotes cell apoptosis in retinoblastoma through the PI3K/Akt signaling pathway [67]. UHRF1 is highly expressed in proliferating and cancer cells, and it has been identified as a novel AMPK gate-keeper in cellular metabolism by interacting with AMPK and suppressing its activity.…”
Section: Discussionmentioning
confidence: 99%